Integrated DNA Technologies and Glycon Partner in Australia
News Apr 19, 2010
Integrated DNA Technologies (IDT) and Glycon Pty Ltd of New South Wales, Australia, are partnering to bring IDT’s products and services to researchers in Australia.
Glycon will offer Australia’s scientists local sales and technical support of IDT’s products, complementing IDT’s existing global customer care network available by phone, email and web chat.
Australian scientists will be able to work directly with Glycon to take the maximum advantage of IDT’s entire product portfolio of synthetic DNA and RNA oligos, genes, and supporting products.
Wendy Scott, Executive Sales Manager of Gylcon explains the benefits of this relationship, “Our experience and knowledge of IDT’s products enables us to provide exceptional customer service and technical expertise. With our background in biomedical science, broad product knowledge base and customer service experience, we can find the most effective solution for all research needs.”
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.READ MORE